• Japanese
  • Korean
  • Chinese
Cover Image

Infectious Immunology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Abstract

Infectious Immunology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Summary

GlobalData's new report, "Infectious Immunology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the global infectious immunology market. The report provides market landscape, competitive landscape and market trends information on the infectious immunology market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Brazil and Australia.
  • Key segments covered include Hepatitis Viruses, Retroviruses, Bacteriology and Other Virology.
  • Annualized market revenues data from 2004 to 2011 and forecast forward for seven years to 2018. Company shares data for 2011.
  • Qualitative analysis of key market trends, market drivers, and restraints within infectious immunology market.
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Qiagen and Gen-Probe Incorporated.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the infectious immunology market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • What's the next big thing in the infectious immunology market landscape? - Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global infectious immunology market and the factors shaping it.

TOC

1 Table of Contents

1 Table of Contents 3

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 GlobalData Report Guidance 7

3 Infectious Immunology Overview 8

  • 3.1 Infectious Immunology: Market Characterization 8
    • 3.1.1 Bacteriology 8
    • 3.1.2 Hepatitis Viruses 9
    • 3.1.3 Other Virology 10
    • 3.1.4 Retroviruses 12

4 Infectious Immunology - Global Market Characterization 13

  • 4.1 Infectious Immunology Market, Global, Revenue ($m), Historic, 2004 - 2011 13
  • 4.2 Infectious Immunology Market, Global, Revenue ($m), Forecast, 2011 - 2018 14
  • 4.3 Infectious Immunology Market, Key Trends 15
    • 4.3.1 New Technological Developments to Change the Infectious Immunology Market Landscape 15
    • 4.3.2 Use of Companion Diagnostics to Provide a Personalized Healthcare Solution for Infectious Disease Treatment can be a Key Focus Area in Future 16
    • 4.3.3 Growing Trend of Development of POCT Tests for Infectious Immunology due to Benefits such as Low Cost and Faster Results 16
  • 4.4 Global Infectious Immunology, Market Dynamics 17
    • 4.4.1 Market Drivers 17
    • 4.4.2 Market Restraints 21

5 Global Infectious Immunology Market: Analysis by Segment 23

  • 5.1 Bacteriology Market, Global, Revenue ($m), Historic, 2004 - 2011 23
  • 5.2 Bacteriology Market, Global, Revenue ($m), Forecast, 2011 - 2018 24
  • 5.3 Bacteriology, Market Dynamics 25
    • 5.3.1 Market Drivers 25
    • 5.3.2 Market Restraint 26
  • 5.4 Hepatitis Viruses Diagnostics Market, Global, Revenue ($m), Historic, 2004 - 2011 28
  • 5.5 Hepatitis viruses diagnostics Market, Global, Revenue ($m), Forecast, 2011 - 2018 29
  • 5.6 Hepatitis Viruses Diagnostics, Market Dynamics 30
    • 5.6.1 Market Drivers 30
    • 5.6.2 Market Restraint 32
  • 5.7 Other Virology Market, Global, Revenue ($m), Historic, 2004 - 2011 35
  • 5.8 Other Virology Market, Global, Revenue ($m), Forecast, 2011 - 2018 36
  • 5.9 Other Virology, Market Dynamics 37
    • 5.9.1 Market Drivers 37
    • 5.9.2 Market Restraint 38
  • 5.10 Retroviruses Market, Global, Revenue ($m), Historic, 2004 - 2011 39
  • 5.11 Retroviruses Market, Global, Revenue ($m), Forecast, 2011 - 2018 40
  • 5.12 Retroviruses, Market Dynamics 41
    • 5.12.1 Market Driver 41
    • 5.12.2 Market Restraint 44

6 Infectious Immunology Market, Analysis by Country, Revenue ($m), 2004 - 2018 45

  • 6.1 Infectious Immunology Market, the US, Revenue ($m), Historic, 2004 - 2011 45
  • 6.2 Infectious Immunology Market, the US, Revenue ($m), Forecast, 2011 - 2018 46
  • 6.3 Infectious Immunology Market, Canada, Revenue ($m), Historic, 2004 -2011 47
  • 6.4 Infectious Immunology Market, Canada, Revenue ($m), Forecast, 2011 - 2018 48
  • 6.5 Infectious Immunology Market, the UK, Revenue ($m), Historic, 2004-2011 49
  • 6.6 Infectious Immunology Market, the UK, Revenue ($m), Forecast, 2011 - 2018 50
  • 6.7 Infectious Immunology Market, Germany, Revenue ($m), Historic, 2004 - 2011 51
  • 6.8 Infectious Immunology Market, Germany, Revenue ($m), Forecast, 2011-2018 52
  • 6.9 Infectious Immunology Market, France, Revenue ($m), Historic, 2004-2011 53
  • 6.10 Infectious Immunology Market, France, Revenue ($m), Forecast, 2011-2018 54
  • 6.11 Infectious Immunology Market, Italy, Revenue ($m), Historic, 2004-2011 55
  • 6.12 Infectious Immunology Market, Italy, Revenue ($m), Forecast, 2011-2018 56
  • 6.13 Infectious Immunology Market, Spain, Revenue ($m), Historic, 2004-2011 57
  • 6.14 Infectious Immunology Market, Spain, Revenue ($m), Forecast, 2011-2018 58
  • 6.15 Infectious Immunology Market, Japan, Revenue ($m), Historic, 2004-2011 59
  • 6.16 Infectious Immunology Market, Japan, Revenue ($m), Forecast, 2011-2018 60
  • 6.17 Infectious Immunology Market, China, Revenue ($m), Historic, 2004-2011 61
  • 6.18 Infectious Immunology Market, China, Revenue ($m), Forecast, 2011-2018 62
  • 6.19 Infectious Immunology Market, India, Revenue ($m), Historic, 2004-2011 63
  • 6.20 Infectious Immunology Market, India, Revenue ($m), Forecast, 2011-2018 64
  • 6.21 Infectious Immunology Market, Australia, Revenue ($m), Historic, 2004-2011 65
  • 6.22 Infectious Immunology Market, Australia, Revenue ($m), Forecast, 2011-2018 66
  • 6.23 Infectious Immunology Market, Brazil, Revenue ($m), Historic, 2004-2011 67
  • 6.24 Infectious Immunology Market, Brazil, Revenue ($m), Forecast, 2011-2018 68

7 Infectious Immunology Market - Strategic Competitive Assessment 69

  • 7.1 Infectious Immunology, Market Share Assessment for Others 70
  • 7.2 Infectious Immunology, Key Market Participants 71
    • 7.2.1 Abbott Laboratories 71
    • 7.2.2 F. Hoffmann-La Roche Ltd. 74
    • 7.2.3 Siemens Healthcare 80

8 Infectious Immunology - Strategic Pipeline Assessment 84

9 Infectious Immunology Market - Strategic Deals Analysis 86

  • 9.1 Infectious Immunology Market, Partnerships, 2010-2012* 87
  • 9.2 Infectious Immunology Market, Venture Financing Deals, 2010-2012* 90
  • 9.3 Infectious Immunology Market, Asset Transaction Deals, 2010-2012* 92
  • 9.4 Infectious Immunology Market, Equity Offering Deals, 2010-2012* 93
  • 9.5 Infectious Immunology Market, Acquisitions, 2010-2012* 94
  • 9.6 Infectious Immunology Market, Debt Offering Deals, 2010-2012* 94
  • 9.7 Infectious Immunology Market, Private Equity Deals, 2010-2012* 95
  • 9.8 Infectious Immunology Market, Mergers, 2010-2012* 95
  • 9.9 Infectious Immunology Market, Licensing Agreement, 2010-2012* 95
  • 9.10 Key Deals 96
    • 9.10.1 Siemens Healthcare Diagnostics and Illumina Entered into a Collaboration Partnership 96
    • 9.10.2 XCyton Announces Receipt of $4.5m from Fidelity Capital Advisors to Launch Novel Diagnostic Platform 'SES' for Critical Infections 96
    • 9.10.3 Abbott Enters into Co-Development Agreement with Genetics Lab for Molecular Assay Development 97
    • 9.10.4 Quanterix, Beth Israel Deaconess and Forsyth Institute Enter into Partnership to Develop a Tuberculosis Test 97

10 Appendix 98

  • 10.1 Market Definitions 98
    • 10.1.1 Infectious Immunology 98
  • 10.2 Acronyms 99
  • 10.3 Sources 101
  • 10.4 Research Methodology 103
    • 10.4.1 Secondary Research 103
    • 10.4.2 Primary Research 104
    • 10.4.3 Models 104
    • 10.4.4 Forecasts 104
    • 10.4.5 Expert Panels 105
  • 10.5 GlobalData Consulting 105
  • 10.6 Contact Us 105
  • 10.7 Disclaimer 105

List of Tables

1.1 List of Tables

  • Table 1: List of Viruses which Commonly Infect Humans, by Nucleic Acid and Family* 10
  • Table 2: Infectious Immunology Market, Global, Revenue ($m), 2004 - 2011 13
  • Table 3: Infectious Immunology Market, Global, Revenue ($m), 2011 - 2018 14
  • Table 4: Home Based Testing Market, by Application and Test Type 19
  • Table 5: Number of Corporate Diagnostic Laboratory Chains, India, 2010 20
  • Table 6: Bacteriology Market, Global, Revenue ($m), 2004 - 2011 23
  • Table 7: Bacteriology Market, Global, Revenue ($m), 2011 - 2018 24
  • Table 8: Bacteriology Market CAGR Comparison, by Country, 2004-2011 27
  • Table 9: Hepatitis Viruses Diagnostics Market, Global, Revenue ($m), 2004 - 2011 28
  • Table 10: Hepatitis viruses diagnostics Market, Global, Revenue ($m), 2011 - 2018 29
  • Table 11: Other Virology Market, Global, Revenue ($m), 2004 - 2011 35
  • Table 12: Other Virology Market, Global, Revenue ($m), 2011 - 2018 36
  • Table 13: Retroviruses Market, Global, Revenue ($m), 2004 - 2011 39
  • Table 14: Retroviruses Market, Global, Revenue ($m), 2011 - 2018 40
  • Table 15: Number of New HIV Infection Cases, the US, 2006-2009 42
  • Table 16: Infectious Immunology Market, the US, Revenue ($m), 2004 - 2011 45
  • Table 17: Infectious Immunology Market, the US, Revenue ($m), 2011 - 2018 46
  • Table 18: Infectious Immunology Market, Canada, Revenue ($m), 2004-2011 47
  • Table 19: Infectious Immunology Market, Canada, Revenue ($m), 2011 - 2018 48
  • Table 20: Infectious Immunology Market, the UK, Revenue ($m), 2004-2011 49
  • Table 21: Infectious Immunology Market, the UK, Revenue ($m), 2011 - 2018 50
  • Table 22: Infectious Immunology Market, Germany, Revenue ($m), 2004 - 2011 51
  • Table 23: Infectious Immunology Market, Germany, Revenue ($m), 2011-2018 52
  • Table 24: Infectious Immunology Market, France, Revenue ($m), 2004-2011 53
  • Table 25: Infectious Immunology Market, France, Revenue ($m), 2011-2018 54
  • Table 26: Infectious Immunology Market, Italy, Revenue ($m), 2004-2011 55
  • Table 27: Infectious Immunology Market, Italy, Revenue ($m), 2011-2018 56
  • Table 28: Infectious Immunology Market, Spain, Revenue ($), 2004-2011 57
  • Table 29: Infectious Immunology Market, Spain, Revenue ($m), 2011-2018 58
  • Table 30: Infectious Immunology Market, Japan, Revenue ($m), 2004-2011 59
  • Table 31: Infectious Immunology Market, Japan, Revenue ($m), 2011-2018 60
  • Table 32: Infectious Immunology Market, China, Revenue ($m), 2004-2011 61
  • Table 33: Infectious Immunology Market, China, Revenue ($m), 2011-2018 62
  • Table 34: Infectious Immunology Market, India, Revenue ($m), 2004-2011 63
  • Table 35: Infectious Immunology Market, India, Revenue ($m), 2011-2018 64
  • Table 36: Infectious Immunology Market, Australia, Revenue ($m), 2004-2011 65
  • Table 37: Infectious Immunology Market, Australia, Revenue ($m), 2011-2018 66
  • Table 38: Infectious Immunology Market, Brazil, Revenue ($m), 2004-2011 67
  • Table 39: Infectious Immunology Market, Brazil, Revenue ($m), 2011-2018 68
  • Table 40: Infectious Immunology Market, Global, Company Share (%), 2011 69
  • Table 41: Abbott Laboratories, Key Marketed Products*, 2011 71
  • Table 42: F. Hoffmann-La Roche Ltd., Key Marketed Products*, 2011 74
  • Table 43: Roche, Infectious Disease Companion Diagnostics Tests, 2011 78
  • Table 44: Siemens Healthcare, Key Marketed Products*, 2011 80
  • Table 45: Siemens Healthcare, Emerging Markets Growth, 2008-2010 82
  • Table 46: Infectious Immunology, Global Pipeline Products, 2011 84
  • Table 47: Infectious Immunology, Global Pipeline Distribution, by Market Segments, 2011 85
  • Table 48: Infectious Immunology Market, Deals, 2010-2012* 86
  • Table 49: Infectious Immunology Market, Partnerships, 2010-2012* 87
  • Table 50: Infectious Immunology Market, Venture Financing Deals, 2010-2012* 90
  • Table 51: Infectious Immunology Market, Asset Transaction Deals, 2010-2012* 92
  • Table 52: Infectious Immunology Market, Equity Offering Deals, 2010-2012* 93
  • Table 53: Infectious Immunology Market, Acquisitions, 2010-2012* 94
  • Table 54: Infectious Immunology Market, Debt Offering Deals, 2010-2012* 94
  • Table 55: Infectious Immunology Market, Private Equity Deals, 2010-2012* 95
  • Table 56: Infectious Immunology Market, Mergers, 2010-2012* 95
  • Table 57: Infectious Immunology Market, Licensing Agreement, 2010-2012* 95

List of Figures

1.2 List of Figures

  • Figure 1: Infectious Immunology, Market Segmentation 8
  • Figure 2: Infectious Immunology Market, Global, Revenue ($m), 2004 - 2011 13
  • Figure 3: Infectious Immunology Market, Global, Revenue ($m), 2011 - 2018 14
  • Figure 4: Global Infectious Immunology, Market Dynamics 17
  • Figure 5: Hub and Spoke Model used by Diagnostic Laboratories 20
  • Figure 6: Innovation Funnel, Biomarker-based Molecular Diagnostic Product 21
  • Figure 7: Bacteriology Market, Global, Revenue ($m), 2004 - 2011 23
  • Figure 8: Bacteriology Market, Global, Revenue ($m), 2011 - 2018 24
  • Figure 9: Bacteriology Market CAGR Comparison, by Country, 2004-2011 26
  • Figure 10: Bacteriology Market, Developed* vs. Developing** Countries, Revenue Contribution (%) 27
  • Figure 11: Hepatitis Viruses Diagnostics Market, Global, Revenue ($m), 2004 - 2011 28
  • Figure 12: Hepatitis viruses diagnostics Market, Global, Revenue ($m), 2011 - 2018 29
  • Figure 13: Hepatitis Testing Market Comparison, Developed* vs. Developing** Markets, 2011 30
  • Figure 14: Estimated New Cases for Hepatitis, the US, 2004-2009 33
  • Figure 15: Other Virology Market, Global, Revenue ($m), 2004 - 2011 35
  • Figure 16: Other Virology Market, Global, Revenue ($m), 2011 - 2018 36
  • Figure 17: Retroviruses Market, Global, Revenue ($m), 2004 - 2011 39
  • Figure 18: Retroviruses Market, Global, Revenue ($m), 2011 - 2018 40
  • Figure 19: Number of New HIV Infection Cases, the US, 2006-2009 42
  • Figure 20: Infectious Immunology Market, the US, Revenue ($m), 2004 - 2011 45
  • Figure 21: Infectious Immunology Market, the US, Revenue ($m), 2011 - 2018 46
  • Figure 22: Infectious Immunology Market, Canada, Revenue ($m), 2004 - 2011 47
  • Figure 23: Infectious Immunology Market, Canada, Revenue ($m), 2011 - 2018 48
  • Figure 24: Infectious Immunology Market, the UK, Revenue ($m), 2004 - 2011 49
  • Figure 25: Infectious Immunology Market, the UK, Revenue ($m), 2011 - 2018 50
  • Figure 26: Infectious Immunology Market, Germany, Revenue ($m), 2004 - 2011 51
  • Figure 27: Infectious Immunology Market, Germany, Revenue ($m), 2011-2018 52
  • Figure 28: Infectious Immunology Market, France, Revenue ($m), 2004-2011 53
  • Figure 29: Infectious Immunology Market, France, Revenue ($m), 2011-2018 54
  • Figure 30: Infectious Immunology Market, Italy, Revenue ($m), 2004-2011 55
  • Figure 31: Infectious Immunology Market, Italy, Revenue ($m), 2011-2018 56
  • Figure 32: Infectious Immunology Market, Spain, Revenue ($m), 2004-2011 57
  • Figure 33: Infectious Immunology Market, Spain, Revenue ($m), 2011-2018 58
  • Figure 34: Infectious Immunology Market, Japan, Revenue ($m), 2004-2011 59
  • Figure 35: Infectious Immunology Market, Japan, Revenue ($m), 2011-2018 60
  • Figure 36: Infectious Immunology Market, China, Revenue ($m), 2004-2011 61
  • Figure 37: Infectious Immunology Market, China, Revenue ($m), 2011-2018 62
  • Figure 38: Infectious Immunology Market, India, Revenue ($m), 2004-2011 63
  • Figure 39: Infectious Immunology Market, India, Revenue ($m), 2011-2018 64
  • Figure 40: Infectious Immunology Market, Australia, Revenue ($m), 2004-2011 65
  • Figure 41: Infectious Immunology Market, Australia, Revenue ($m), 2011-2018 66
  • Figure 42: Infectious Immunology Market, Brazil, Revenue ($m), 2004-2011 67
  • Figure 43: Infectious Immunology Market, Brazil, Revenue ($m), 2011-2018 68
  • Figure 44: Infectious Immunology Market, Global, Company Shares (%), 2011 69
  • Figure 45: Infectious Immunology, Market Share Assessment for Others 70

Figure 46: Abbott Laboratories, SWOT Analysis 72

Figure 47: F. Hoffmann-La Roche Ltd., SWOT Analysis 76

  • Figure 48: Roche, Revenue Distribution by Geography, 2011 79

Figure 49: Siemens Healthcare, SWOT Analysis 81

  • Figure 50: Siemens Healthcare, Revenue Share, by Region, 2010 81
  • Figure 51: Siemens Healthcare, Emerging Markets Growth, 2008-2010 82
  • Figure 52: Infectious Immunology, Global Pipeline Products, 2011 84
  • Figure 53: Infectious Immunology, Global Pipeline Distribution, by Market Segment, 2011 85
  • Figure 54: Infectious Immunology Market, Deals, 2010-2012* 86
Show More
Pricing